2827:HK:HK-W.I.S.E. CSI300 China Tracker (HKD)

ETF | Others |

Last Closing

USD 36.34

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

World Index Shares ETFs - CSI 300 China Tracker is an exchange traded fund launched and managed by BOCI - Prudential Asset Management Limited. It invests in the public equity markets of China. The fund uses derivatives such as A-share access products (AXPs) to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of large-cap companies. The fund seeks to replicate the performance of the CSI 300 Index, by employing synthetic replication methodology. World Index Shares ETFs - CSI 300 China Tracker was formed on July 13, 2007 and is domiciled in Hong Kong.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Others

ETFs Containing 2827:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.42% 72% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.42% 72% C 69% C-
Trailing 12 Months  
Capital Gain 7.20% 67% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.20% 67% D+ 65% D
Trailing 5 Years  
Capital Gain 6.57% 61% D- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.57% 61% D- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain -1.15% N/A N/A 58% F
Dividend Return -1.15% N/A N/A 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 23.58% N/A N/A 63% D
Risk Adjusted Return -4.88% N/A N/A 54% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike